Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals Inc Stock (ORMP) Forecast

The Oramed Pharmaceuticals Inc (ORMP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.02, representing a +89.10% increase from the current price of $3.71. The highest analyst price target is $6.61, and the lowest is $7.42.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ORMP Price Target

Average 11.83 (+218.75% Upside)

Is Oramed Pharmaceuticals Inc (ORMP) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	34.41	Neutral
STOCH(9,6)	31.82	Neutral
STOCHRSI(14)	7.42	Buy
MACD(12,26)	-0.12	Sell
ADX(14)	26.64	Sell
William %R	-93.55	Buy
CCI(14)	-161.98	Sell

Buy: 2 · Sell: 3 · Neutral: 2Summary: Sell

Moving Averages

Period	Simple	Exponential
MA10	3.97 Sell	3.98 Sell
MA20	4.05 Sell	4.06 Sell
MA50	4.36 Sell	4.24 Sell
MA100	4.41 Sell	4.25 Sell
MA200	4.06 Sell	3.96 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, ORMP could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ORMP, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 34.41 indicates that ORMP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 31.82 indicates that ORMP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.42 indicates that ORMP is oversold. This suggests that ORMP price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 26.64 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
CCI (Commodity Channel Index): A CCI(14) value of -161.98 indicates that ORMP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term ORMP price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Oramed Pharmaceuticals Inc financial reports and earnings history, Oramed Pharmaceuticals Inc (ORMP) stock could reach $9.32 by 2030, $45.56 by 2040 and $99.40 by 2050. See the projected annual prices until 2050 of the Oramed Pharmaceuticals Inc stock below:

Oramed Pharmaceuticals Inc (ORMP) is expected to reach an average price of $19.13 in 2035, with a high prediction of $26.10 and a low estimate of $19.17. This indicates an +415.55% change from the last recorded price of $3.71.
Oramed Pharmaceuticals Inc (ORMP) stock is projected to chart a bullish course in 2040, with an average price target of $36.73, representing an +890.00% change from its current level. The forecast ranges from a conservative $36.84 to a sky-high $45.56.
Our analysts predict Oramed Pharmaceuticals Inc (ORMP) to change +1,492% by 2045, soaring from $59.17 to an average price of $59.05, potentially reaching $70.32. While $59.17 is the low estimate, the potential upside is significant.
Oramed Pharmaceuticals Inc (ORMP) stock is expected to climb by 2050, reaching an average of $85.95, a +2,217% change from its current level. However, a wide range of estimates exists, with high and low targets of $99.40 and $80.40, respectively, highlighting the market's uncertainty.

Oramed Pharmaceuticals Inc Stock (ORMP) Year by Year Forecast

Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2026

The predicted value for Oramed Pharmaceuticals Inc (ORMP) in 2026 is set at an average of $4.26. Estimates vary from a peak of $6.61 to a trough of $2.83, indicating an +14.70% surge from the present price of $3.71.

Month	Average	Low	High	Change from today's price
December, 2026	$6.89	$7.42	$6.61	+85.73%

Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Oramed Pharmaceuticals Inc (ORMP) is $12.89, with a high forecast of $16.23 and a low forecast of $9.62. This indicates an +247.38% increase from the last price of $3.71.

Month	Average	Low	High	Change from today's price
January, 2027	$13.23	$9.62	$11.04	+256.59%
February, 2027	$10.55	$10.79	$13.02	+184.32%
March, 2027	$12.44	$11.38	$11.75	+235.19%
April, 2027	$12.63	$12.29	$12.37	+240.41%
May, 2027	$15.88	$13.35	$15.03	+327.94%
June, 2027	$16.05	$16.07	$15.88	+332.62%
July, 2027	$15.51	$16.24	$16.23	+318.17%
August, 2027	$11.34	$12.09	$15.53	+205.69%
September, 2027	$10.68	$11.17	$11.15	+187.74%
October, 2027	$11.03	$11.43	$11.05	+197.27%
November, 2027	$12.98	$11.94	$12.79	+249.76%
December, 2027	$12.35	$12.10	$12.09	+232.88%

Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2028

In 2028, Oramed Pharmaceuticals Inc (ORMP) is projected to reach an average price of $12.86, with a high projection of $15.98 and a low estimate of $7.26. This indicates an +246.67% rise from the last price of $3.71.

Month	Average	Low	High	Change from today's price
January, 2028	$9.97	$10.74	$11.32	+168.65%
February, 2028	$6.32	$7.96	$9.82	+70.37%
March, 2028	$16.14	$7.26	$15.98	+335.16%
April, 2028	$15.64	$15.70	$15.98	+321.52%
May, 2028	$15.26	$15.49	$15.56	+311.20%
June, 2028	$14.98	$15.11	$15.18	+303.76%
July, 2028	$12.43	$13.90	$14.81	+234.95%
August, 2028	$12.76	$12.75	$12.52	+243.87%
September, 2028	$12.88	$12.77	$12.75	+247.28%
October, 2028	$12.60	$12.77	$12.86	+239.66%
November, 2028	$12.48	$12.62	$12.59	+236.26%
December, 2028	$12.89	$12.39	$12.46	+247.41%

Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2029

The 2029 price forecast for Oramed Pharmaceuticals Inc Stock (ORMP) is $11.14 on average, with a high prediction of $13.18 and a low estimate of $9.71. This represents an +200.20% increase from the previous price of $3.71.

Month	Average	Low	High	Change from today's price
January, 2029	$13.31	$12.92	$13.15	+258.66%
February, 2029	$12.84	$13.02	$13.18	+246.09%
March, 2029	$12.38	$12.52	$12.53	+233.79%
April, 2029	$11.95	$12.08	$12.08	+222.13%
May, 2029	$11.27	$11.37	$11.87	+203.90%
June, 2029	$10.47	$10.55	$11.01	+182.17%
July, 2029	$10.51	$10.40	$10.49	+183.17%
August, 2029	$10.70	$10.79	$10.68	+188.40%
September, 2029	$10.59	$10.63	$10.61	+185.53%
October, 2029	$10.26	$10.38	$10.43	+176.56%
November, 2029	$9.74	$9.79	$9.78	+162.65%
December, 2029	$9.62	$9.71	$9.63	+159.34%

Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2030

Oramed Pharmaceuticals Inc Stock (ORMP) is expected to reach an average price of $7.83 in 2030, with a high forecast of $9.32 and a low forecast of $6.40. This signifies an +110.96% surge from the last price of $3.71.

Month	Average	Low	High	Change from today's price
January, 2030	$9.21	$9.40	$9.32	+148.12%
February, 2030	$9.08	$9.06	$9.09	+144.72%
March, 2030	$8.78	$8.91	$8.93	+136.73%
April, 2030	$8.46	$8.53	$8.71	+128.03%
May, 2030	$8.19	$8.22	$8.15	+120.86%
June, 2030	$8.02	$7.99	$8.05	+116.11%
July, 2030	$7.81	$7.85	$7.89	+110.64%
August, 2030	$7.37	$7.39	$7.68	+98.61%
September, 2030	$7.22	$7.23	$7.34	+94.50%
October, 2030	$6.85	$6.89	$6.96	+84.63%
November, 2030	$6.61	$6.83	$6.78	+78.26%
December, 2030	$6.32	$6.40	$6.50	+70.37%